Intellia Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 11/12/2025 | 11.92 M | $205.84 M | -8.44% | 10.82% |
| VANGUARD GROUP INC | 11/07/2025 | 11.04 M | $190.74 M | 1.78% | 10.02% |
| BLACKROCK, INC. | 11/12/2025 | 9.28 M | $160.19 M | -7.49% | 8.42% |
| MORGAN STANLEY | 11/14/2025 | 6.02 M | $104.01 M | 46.29% | 5.47% |
| CONTRARIUS GROUP HOLDINGS LTD | 11/12/2025 | 5.89 M | $101.72 M | 279.38% | 5.35% |
| STATE STREET CORP | 11/14/2025 | 4.97 M | $85.85 M | 23.06% | 4.51% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 4.28 M | $73.89 M | 109.00% | 3.88% |
| REGENERON PHARMACEUTICALS, INC. | 11/07/2025 | 3.70 M | $63.95 M | 0.00% | 3.36% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 2.75 M | $47.44 M | 2.65% | 2.49% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.59 M | $44.71 M | -0.67% | 2.35% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 2.45 M | $42.30 M | 7.60% | 2.22% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 10/27/2025 | 2.35 M | $40.67 M | -11.84% | 2.14% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 11/12/2025 | 2.35 M | $40.62 M | -11.84% | 2.14% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 2.23 M | $38.48 M | 170.20% | 2.02% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 2.16 M | $37.36 M | 3.36% | 1.96% |
| FMR LLC | 11/13/2025 | 1.85 M | $31.99 M | 21.82% | 1.68% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 1.76 M | $30.35 M | -5.84% | 1.59% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 1.61 M | $27.81 M | 3.67% | 1.46% |
| JUPITER ASSET MANAGEMENT LTD | 11/10/2025 | 1.36 M | $23.52 M | 100.00% | 1.24% |
| UBS GROUP AG | 11/13/2025 | 1.11 M | $19.14 M | 25.81% | 1.01% |
| NORTHERN TRUST CORP | 11/14/2025 | 906.29 K | $15.65 M | -0.30% | 0.82% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 890.36 K | $15.38 M | 16.54% | 0.81% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 873.19 K | $15.08 M | 1.94% | 0.79% |
| STIFEL FINANCIAL CORP | 11/12/2025 | 778.52 K | $13.44 M | -0.83% | 0.71% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 672.00 K | $11.61 M | 3.38% | 0.61% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 651.00 K | $11.24 M | -3.83% | 0.59% |
| MAREX GROUP PLC | 11/14/2025 | 622.60 K | $10.75 M | -0.16% | 0.57% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 607.56 K | $10.49 M | -26.89% | 0.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2025 | 607.20 K | $10.49 M | 100.00% | 0.55% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 605.53 K | $10.46 M | 41.10% | 0.55% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 11/13/2025 | 565.13 K | $9.76 M | -22.52% | 0.51% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 539.82 K | $9.32 M | 126.41% | 0.49% |
| UBS GROUP AG | 11/13/2025 | 495.88 K | $8.56 M | 106.01% | 0.45% |
| IQ EQ FUND MANAGEMENT (IRELAND) LTD | 11/05/2025 | 494.47 K | $8.54 M | 67.97% | 0.45% |
| BARCLAYS PLC | 11/12/2025 | 488.23 K | $8.43 M | -5.77% | 0.44% |
| DIADEMA PARTNERS LP | 11/14/2025 | 470.20 K | $8.12 M | 100.00% | 0.43% |
| JPMORGAN CHASE & CO | 11/26/2025 | 440.57 K | $7.61 M | -53.15% | 0.42% |
| ROYAL BANK OF CANADA | 11/14/2025 | 464.53 K | $8.02 M | -7.97% | 0.42% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 446.70 K | $7.71 M | 183.26% | 0.41% |
| INVESCO LTD. | 11/13/2025 | 409.42 K | $7.07 M | 62.74% | 0.37% |
| CITADEL ADVISORS LLC | 11/14/2025 | 375.10 K | $6.48 M | 55.58% | 0.34% |
| STEADFAST CAPITAL MANAGEMENT LP | 11/14/2025 | 365.40 K | $6.31 M | 100.00% | 0.33% |
| PEAK6 LLC | 11/14/2025 | 343.90 K | $5.94 M | 122.73% | 0.31% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 342.59 K | $5.92 M | -62.50% | 0.31% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 316.95 K | $5.47 M | 6.11% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 313.05 K | $5.41 M | 0.60% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 309.60 K | $5.35 M | 34.73% | 0.28% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 300.00 K | $5.18 M | 100.00% | 0.27% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 11/10/2025 | 297.57 K | $5.14 M | -53.38% | 0.27% |
| JUMP FINANCIAL, LLC | 11/13/2025 | 275.99 K | $4.77 M | -39.56% | 0.25% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Intellia Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 404 institutional investors and hedge funds held shares of Intellia Therapeutics, Inc.. The most heavily invested institutionals were:
ARK Investment Management LLC: 11.92 M
VANGUARD GROUP INC: 11.04 M
BlackRock, Inc.: 9.28 M
MORGAN STANLEY: 6.02 M
Contrarius Group Holdings Ltd: 5.89 M
STATE STREET CORP: 4.97 M
94.54% of Intellia Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 121.79 M shares in the last 24 months. This purchase volume represents approximately $2.43 B in transactions.